Scientists working at the European Molecular Biology Laboratory (EMBL) in Grenoble, France have developed a new technique that enables them to introduce up to 15 fluorescent markers to a mammalian cell in one go. They say their findings could help speed up drug development and screening.

The potential of mHealth solutions has been discussed for many years, but only recently, with the advent of the new smartphone application based mHealth model, have pharmaceutical companies begun to realize how mobile services might be instrumental in the development of exciting innovations in their own businesses.

Half of Europeans using the Internet for health information are interested in online patient education programs from pharmaceutical companies, although just a small fraction are currently using these types of programs, according to Manhattan Research's Cybercitizen Health® Europe v10.0 research.

Starting today, people from all corners of the world are uniting together for three days of celebration to put diabetes firmly in the public spotlight. World Diabetes Day is the best opportunity there is to draw attention to the silent killer that is diabetes.

Using mild painkillers in pregnancy appears to raise the risk of cryptorchidism (undescended testicles) in baby boys, new EU-funded research suggests. The findings offer an explanation of why cryptorchidism, which is the biggest risk factor for poor semen quality and testicular cancer in later life, is becoming more common.

With fast-paced advancements in genomics, combinatorial chemistry, and high-throughput screening, China has emerged as a major location to which drug discovery is being outsourced. China has the advantages of scientific expertise and comprehensive infrastructure, which are critical for drug discovery activities.

Pharmaceutical and healthcare market research company Manhattan Research releases its latest report, "Consumer Online Health Video: Understanding Consumption Patterns to Optimize Implementation".